Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 3,148

Document Document Title
WO/2007/068580A1
The invention concerns novel biphenyl derivatives and their use for preparing a pharmaceutical or cosmetic composition for preventing and/or treating pathological conditions in which a selective agonist activity for the gamma subtype of ...  
WO/2007/056500A2
Disclosed herein are novel di-aromatic compounds and methods for using various di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors.  
WO/2007/045367A1
The present application relates to novel cyclopropylacetic acid derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment an...  
WO/2007/045433A1
The present application relates to dicarboxylic acid derivatives of general formula (I), methods for preparing the same, their use for the treatment and/or prevention of diseases, and their use for producing medicaments for the treatment...  
WO/2007/044184A1
This invention provides both metal carboxylates and tertiary ammonium carboxylates, in which carboxylates a benzoylphenyl group is present. Also provided are photoinitiator compositions which comprise a) (i) at least one metal carboxylat...  
WO/2007/034924A1
Disclosed is a metallo-β-lactamase inhibitor which can inactivate a β-lactam antibiotic and recover the anti-bacterial activity of the β-lactam antibiotic. A maleic acid derivative having a structure of the general formula (I) has an ...  
WO/2007/033192A1
. The present invention provides salt forms of the formula below wherein R is H or OH, and compositions thereof, useful as modulators of one or more GPCRs and which exhibit desirable characteristics for the same.  
WO/2007/020795A1
Gallic acid derivatives represented by the general formula (1): [wherein R1 is hydrogen, alkali metal, alkaline earth metal, transition metal, substituted or unsubstituted ammonium, or alkyl or alkenyl having 1 to 22 carbon atoms; and R2...  
WO/2007/021001A1
A 2,3,4-trifluoro-5-substituent-benzoic acid compound represented by the general formula (1): (wherein Y represents iodine, formyl, or an electrophilic species; and M represents hydrogen or a metal); a process for producing the compound;...  
WO/2007/013471A1
Compounds represented by the general formula (I) or (I’) wherein R11 to R13 are each alkyl having 1 to 10 carbon atoms; s is an integer of 1 to 2; t is an integer of 1 to 3; u is an integer of 1 to 3; the sum of s, t and u is an intege...  
WO/2007/008888A2
A method of making an aromatic dihydroxy diacid dihalide comprises forming a solution of an aromatic dihydroxy diacid in a solvent, contacting the aromatic dihydroxy diacid solution with a halogenating agent; heating the solution under a...  
WO/2007/005531A2
Non-nucleoside inhibitors of HIV-I reverse transcriptase are described. Such inhibitors may be used as part of a combination therapy to treat HIV infection. Compounds described herein exhibit antiviral potency. In addition, compounds des...  
WO/2006/132442A1
Disclosed are a compound represented by the general formula (I): (I) or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound or the like; and others. The compound or pharmaceutically acceptable...  
WO/2006/128542A1
The invention relates to salts from at least one imidazole of general formula (I), wherein R1, R2, R3 and R4 are the same or different and represent hydrogen, an alkyl group with 1 to 20, preferably 1 to 10, especially 1 to 4 carbon atom...  
WO/2006/123672A1
Disclosed is a method for commercially producing an aminoalcohol derivative (I) having a biphenyl group. Also disclosed are a biphenyloxyacetaldehyde derivative used therefor, a method for producing such a biphenyloxyacetaldehyde derivat...  
WO/2006/121390A2
Compounds of formula I, wherein Y = H, -OH, halo, -OC1-6alkyl, -C1-6alkyl, the two latter optionally substituted with halo, -CN, -OH, -CF3, -NH2; Rl = -C3-6cycloaUcyl, heterocycloalkyl, aryl, alkylaryl, heteroaryl, -C3-6-alkyl, optionall...  
WO/2006/108717A2
The present invention relates to a novel method for preparing 6- [3- ( 1 - adamantyl ) -4-methoxyphenyl] -2- naphthoic acid.  
WO/2006/092081A1
The invention provides structures of active compounds isolated from medicinal herbal of Euphorbia Lunulata and the use thereof. These compounds possess insulin- or IL-10-like activity, wherein the structures of compounds (1), (2), (4), (...  
WO/2006/088716A1
The present invention relates to novel tetralin ER-β agonist compounds, pharmaceutical compositions thereof, and use of these compounds to treat a ER-β mediated disease such as nocturia, obstructive uropathy, benign prostatic hypertrop...  
WO/2006/085630A1
A process for producing an aromatic dicarboxylic acid of the formula: (1) (wherein R1 to R6 each independently is hydrogen, an alkyl or an aryl, and may be identical with or different from each other), comprising the first step of reacti...  
WO/2006/077884A1
[PROBLEMS] To impart an antiglare effect to a laminated glass making use of a polyvinyl butyral resin as an intermediate film without coloring the same. [MEANS FOR SOLVING PROBLEMS] There is provided an intermediate film of laminated gla...  
WO/2006/069678A1
The invention relates to conjugates of metal complex hydroxypyridin derivatives and biomolecules and to the production thereof. Said conjugates are suitable for use in the form of contrast agents in NMR diagnosis. The special embodiment ...  
WO/2006/069685A1
The invention relates to compounds of formula (I), where A1, A2, R1, R2, R3, R4, R5 and Y have the meanings given in the description, methods and intermediates for production thereof and use thereof for the prevention of pests.  
WO/2006/066975A1
Process for the preparation of aryl or vinyl carboxylic acids via Pd-catalysed hydroxycarbonylation of aryl and vinyl bromides, wherein the aryl or vinyl bromides are reacted with a carbon monoxide source comprising lithium formate and a...  
WO/2006/069153A2
The present invention relates to novel, non-secosteroidal, phenyl-naphthalene compounds of Formula (I): wherein R, R1, RP, ZP, LP1, LP2 LNP, RP3, RN, and ZNP are defined herein, their preparation, pharmaceutical compositions, and methods...  
WO/2006/058648A2
The present invention relates to compounds of Formula (I) wherein Ar, Ar2, R2, R3, R4, m, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and...  
WO/2006/046593A1
Disclosed is an excellent LXR modulator. Specifically disclosed is a compound represented by the general formula (I) below or the like. (I) [In the formula, R1 represents a -COR9 (wherein R9 represents an alkyl, optionally substituted al...  
WO/2006/037449A2
This invention relates to certain iron complexes which comprise ferrous or ferric iron and mono-, bi-, tri- or hexadentate ligands containing a five- or six-membered aromatic or heterocyclic ring for use in the treatment and/or preventio...  
WO/2006/037480A1
The invention is concerned with hexafluoroisopropanol substituted ether derivatives of formula (I), wherein Rl to R3 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. The...  
WO/2006/022252A1
Disclosed is a selective demethylation process of a 2-methoxy group. Specifically disclosed is a method for producing a compound represented by the formula (7) below through the following reactions.  
WO/2006/011469A1
A cyclohexane derivative having the function of reducing a blood sugar level and having preferable properties required of medicines, such as long-lasting drug activity, metabolic stability, and safety; and a medicinal composition for use...  
WO/2006/003395A2
A molten salt is described comprising a quinone or quinone derivative as anion or cation. A process for the production of hydrogen peroxide is also described comprising the steps of reducing the molten salt to produce a corresponding hyd...  
WO/2006/002185A1
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen receptor modulation.  
WO/2005/123652A1
A rare earth metal complex represented by the formula (1) below emits very monochromatic light which is derived from the rare earth metal ions, and provides a light-emitting material having high luminous (quantum) efficiency and excellen...  
WO/2005/123651A1
The present invention relates to new L-2-(&agr -hydroxypentyl) benzoates and the preparation thereof, and to the pharmaceutical compositions in which the compounds are used as active ingredients. The invention also relates to the use of ...  
WO/2005/121061A1
Disclosed herein is a novel process for producing Sodium dihydrate salt of Ibuprofen of Formula (Structure I) by treating a salt of long chain carboxylic acid of Formula (Structure III) with Ibuprofen of Formula (Structure II) in the pre...  
WO/2005/116010A1
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressur...  
WO/2005/115075A2
The present invention provides L-arginine salts of 4-ammosalicylic acid and 5-ammosalicylic acid (mesalamine) Pharmaceutical compositions containing these L-argmme salts are useful for the treatment of inflammatory conditions of the gast...  
WO/2005/108337A2
Disclosed herein are novel di-phenyl compounds and methods for using various di-phenyl compounds for treatment and prevention of diseases and disorders related to estrogen receptors.  
WO/2005/100297A1
The inventive indene derivatives of formula (I) are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs), causing no adverse side effects, and thus, they are useful for the treatment and...  
WO/2005/097773A1
The present invention is related to carboxylic acids of Formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and...  
WO/2005/095319A1
A method for producing a carboxylic acid compound represented by the following formula (3) (wherein n is as defined below) is characterized in that an organic layer containing a carboxylic acid compound represented by the above formula (...  
WO/2005/095360A1
Neurologically-active heterocyclic compounds comprising two fused 6-membered rings with nitrogen atoms at positions 1 and 3, a carboxy group at position 4,and a hydroxy group at position 8, with one ring being aromatic. Processes for the...  
WO/2005/087701A1
The present invention relates to novel compounds 2-(&agr -n­pentanonyl)benzoates, their preparation method, the pharmaceutical composition containing the same, and their use in preparing the medicine for preventing and/or treating cardi...  
WO/2005/087700A2
The present invention discloses bisphenyl compounds of the formula (1): wherein R1, R2, R3, R4, R5, R6, X, Y, W are defined herein after. These compounds are useful as pharmaceuticals.  
WO/2005/085168A1
Particles of aluminum salt hydroxide containing an organic acid anion represented by the general formula (1): Ma[Al1-xM’x]bAzBy(OH)n·mH2O (1) [wherein M represents at least one cation selected from the group consisting of Na+, K+, NH4...  
WO/2005/085189A2
The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts thereof, wherein X is selected from (II) and (III), Y is selected from SO2NH, CONH, CH=N, CH2NH and CH=CH; R1-5 are each independently select...  
WO/2005/063222A1
An Hsp90 family protein inhibitor which contains as an active ingredient a benzene derivative represented by the following general formula (I), a prodrug thereof, or a pharmacologically acceptable salt of either.  
WO/2005/061427A2
The invention relates to a method for the production of a compound according to general formula (I), wherein a) a compound (II) is reacted with a compound (III) in the presence of a base B1 and b) the compound (IV) formed in step a) as a...  
WO/2005/058791A1
A carboxylic acid compound represented by the formula (1); [Chemical formula 1] and an epoxy compound having a structural unit derived from the carboxylic acid compound and an epoxy group.  

Matches 351 - 400 out of 3,148